August 29, 2018 11:55 am
Updated: August 30, 2018 4:42 pm

B.C. government launches lawsuit against opioid manufacturers to recoup overdose crisis costs

The NDP government has launched a class-action lawsuit against 40 companies that produce and distribute opioids, seeking damages for the drug overdose crisis across the province. Ted Chernecki reports.

A A

The British Columbia government announced Wednesday it is suing 40 companies in connection with manufacturing opioids.

The province is looking to recoup healthcare costs associated with the province’s ongoing opioid epidemic that has killed thousands.

“Opioid misuse and addiction has taken a terrible toll on thousands of families and individuals in British Columbia. These British Columbians deserve our determination and support to end this epidemic,” said Attorney General David Eby.

WATCH: Is B.C.’s opioid lawsuit a case of deja vu?


Story continues below

This is the first lawsuit of its kind in Canada, with a government taking direct legal action against drug companies in connection with opioid addiction and overdose deaths.

A majority of overdose deaths have included people who become addicted to prescription opioids and then either continue to use the drugs or search alternatives that have frequently been laced with fentanyl.

There were 1,422 overdose deaths in 2017, a 43 per cent increase compared to 2016, which saw 914 deaths. So far, 2017 was the deadliest year in B.C.’s history for overdose deaths.

READ MORE: B.C. marks 2017 as deadliest O.D. death year in provincial history

WATCH: B.C. claims drug makers marketed products while downplaying inherent risks.

At the heart of the lawsuit is Purdue Pharma. Victims have attempted to seek damages by filing a class action lawsuit against the company. It led to a proposed $20-million settlement, with $2 million going to the provinces and territories and no admission of guilt. The settlement has stalled.

Purdue Pharma has lost a number of court cases in the United States. The company promoted the pain killer OxyContin as safer and less addictive than other opioids. The company has acknowledged in the United States that its marketing of OxyContin was misleading and paid US$634.5 million in 2007 to settle criminal and civil charges.

“I think what is very clear is that there have been few options that have been tried to date in Canada despite the ongoing crisis and I think trying this legal avenue is long overdue,” said Matthew Herder, the director of the Health Law Institute at Dalhousie University. “But whether it is successful, that is hard to say. There will be important factual questions about how much these different companies knew or ought to have known.”

WATCH: B.C government announces plans to sue opioid drug makers

Because there are so many companies involved, Herder expects the lawsuits to be dragged out and it could be years until there are any court resolutions. But Herder says one of the strong cases the B.C. government has is that drug users often are prescribed opioids that lead to their addiction.

“Many folks who become unfortunately addicted to opioid medication or stronger things that are available on the streets started on a pathway to that outcome from prescription drugs that will be the subject of this litigation,” said Herder.

In a statement to Global News, Purdue Pharma said it is reviewing the claim filed by the B.C. government.

“The opioids crisis is a complex and multifaceted public health issue that involves both prescription opioids and, increasingly, illegally produced and consumed opioids, as indicated in Health Canada’s latest quarterly monitoring report,” the statement said.

“All stakeholders, including the pharmaceutical industry, have a role to play in providing practical and sustainable solutions.”

The company went on to say that it “has always adhered to all Health Canada and international regulations.”

— With files from Jon Azpiri

 

© 2018 Global News, a division of Corus Entertainment Inc.

Report an error

Comments

Want to discuss? Please read our Commenting Policy first.